Cierra N. Sharp

Cierra N. Sharp

May 23, 2016

Group 6 Copy 52
0
    Please wait...

    About This Project

    A major dose-limiting toxicity of some chemotherapeutics (like cisplatin) is nephrotoxicity, leading to acute kidney injury (AKI) in 30% of patients. The aim of my project is to develop a mouse model that recapitulates the dosing regimen humans receive in order to develop and test novel renoprotective agents. This is important as there are no therapeutic interventions for cisplatin-induced AKI, and no long-term studies on kidney function have been performed in mice treated with cisplatin.

    Blast off!

    Browse Other Projects on Experiment

    Related Projects

    Understanding Avian Diversity: a genomic approach to determine the relationships of Kingfishers and their allies

    Understanding biodiversity is fundamental to biology. To do so, we need to know the evolutionary tree of...

    Can gelatine lifters collect human DNA off trafficked animal specimens?

    We hypothesize that human DNA can be collected off of animal specimens using forensic gelatin lifters. We...

    Probiotics for plants? Fighting insects by boosting corn immune systems

    Beneficial soil microorganisms can boost the plant immune system. We want to know if farming practices that...

    Backer Badge Funded